The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel cardiovascular disease risk score for prediction of atherosclerotic disease events in men with prostate cancer.
 
Nickolas Stabellini
No Relationships to Disclose
 
Min Choon Tan
No Relationships to Disclose
 
Jennifer Cullen
Patents, Royalties, Other Intellectual Property - Provisional Patent Application No. 62/888,890 ; Title: PROTEIN PANELS FOR THE EARLY DIAGNOSIS/PROGNOSIS OF AGGRESSIVE PROSTATE CANCER; Filed on August 19, 2019
 
Neal L Weintraub
No Relationships to Disclose
 
John Shanahan
No Relationships to Disclose
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Sagar A. Patel
No Relationships to Disclose
 
Alberto J. Montero
Honoraria - AstraZeneca; Celgene; OncoSec
Consulting or Advisory Role - New Century Health; Paragon healthcare; Welwaze
(OPTIONAL) Uncompensated Relationships - Roche
 
Avirup Guha
Employment - AstraZeneca (I)
Consulting or Advisory Role - Myovant Sciences; Novartis; Pfizer
Research Funding - Sumitovant Biopharma (Inst)